COVID-19 trials registries data warehouse

 Return to trial list

Trial - NCT04844580


Column Value
Trial registration number NCT04844580
Full text link
Last imported at : April 16, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

First author
Last imported at : April 16, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

Erdem Ozdemir

Contact
Last imported at : April 16, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

ErdemOzdemir@centurion.com.tr

Registration date
Last imported at : April 16, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

2021-04-14

Recruitment status
Last imported at : June 6, 2023, 8 a.m.
Source : ClinicalTrials.gov

Completed

Study design
Last imported at : April 16, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

RCT

Allocation
Last imported at : April 16, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

Randomized

Design
Last imported at : April 16, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

Parallel

Masking
Last imported at : April 16, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

Blind label

Center
Last imported at : April 16, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

multi-center

Study aim
Last imported at : April 16, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

Treatment

Inclusion criteria
Last imported at : April 16, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

inclusion criteria: 1.18 years and older women or men, under 70 years old 2.patients with positive sars-cov-2 real time pcr result and an appearance in line with covid-19 pneumonia on thorax ct 3. need for oxygen support or spo2 <94 in room air 4. patients who can use a nebulizer (with assistance when necessary) 5.patients who are willing and capable (mentally and physically) who can sign a written informed consent form, to participate in all aspects of the study, to participate in the planned visits and to comply with the terms of the protocol.

Exclusion criteria
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov

intensive care admission the need for mechanical ventilation patients with previously known organ (kidney, heart and liver) failure * to be determined as previously known heart failure (ef <30), previously known liver failure (child-pugh c) and previously known renal failure (cr.clerance <30). covid-19 disease with no indication for hospitalization participants in another clinical trial pregnancy or lactation solid organ or stem cell transplantation story patients with collagen tissue disease use of immunosuppressive therapy procalcitonin ≥2 (baseline visit) under 18 years old those who had myocardial infarction in the last 3 months those who do not have the capacity to understand the possible results, scope and nature of the study due to legal insufficiency and / or other reasons. those who, in the opinion of the investigator, cannot continue the treatment protocol regularly or cannot cooperate presence of malignancy patients with neurological diseases

Number of arms
Last imported at : April 16, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

2

Funding
Last imported at : April 16, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

Centurion Pharma

Inclusion age min
Last imported at : April 16, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

18

Inclusion age max
Last imported at : April 16, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

70

Countries
Last imported at : April 16, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

Turkey

Type of patients
Last imported at : April 16, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

Moderate/severe disease at enrollment

Severity scale
Last imported at : April 16, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

4: Moderate/severe disease at enrollment

Total sample size
Last imported at : April 16, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

80

primary outcome
Last imported at : April 16, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

Clinical improvement

Notes
Last imported at : April 16, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

None

Phase
Last imported at : April 16, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

Phase 2

Arms
Last imported at : April 16, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

[{"arm_notes": "Inhaled", "treatment_id": 155, "treatment_name": "Aviptadil (vasoactive intestinal peptide)", "treatment_type": "Cardiovascular agents", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]